CN107884529A - A kind of method and its application for determining fat emulsion formulation entrapment efficiency - Google Patents

A kind of method and its application for determining fat emulsion formulation entrapment efficiency Download PDF

Info

Publication number
CN107884529A
CN107884529A CN201610861952.1A CN201610861952A CN107884529A CN 107884529 A CN107884529 A CN 107884529A CN 201610861952 A CN201610861952 A CN 201610861952A CN 107884529 A CN107884529 A CN 107884529A
Authority
CN
China
Prior art keywords
elution
anion
fat emulsion
medicine
weak
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610861952.1A
Other languages
Chinese (zh)
Other versions
CN107884529B (en
Inventor
薛雁
石健丽
刘宏大
齐琰
王宏英
丁忠福
李萍
石皎
孙东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuanda Life Science (Liaoning) Co.,Ltd.
Original Assignee
Liaoning Yuanda Nuokang Bio-Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Yuanda Nuokang Bio-Pharmaceuticals Co Ltd filed Critical Liaoning Yuanda Nuokang Bio-Pharmaceuticals Co Ltd
Priority to CN201610861952.1A priority Critical patent/CN107884529B/en
Publication of CN107884529A publication Critical patent/CN107884529A/en
Application granted granted Critical
Publication of CN107884529B publication Critical patent/CN107884529B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

The present invention provides a kind of method for determining Fat Emulsion entrapment efficiency, the described method comprises the following steps:(1) weak-base anion-exchange resin is filled in column jecket, be dehydrated;(2) fat emulsion formulation of anion-containing medicine is added in column jecket, then eluted;(3) Fat Emulsion afforded is collected, the entrapment efficiency of fat emulsion formulation is calculated according to the dosage of the medicine of fat emulsion formulation before the content for the medicine being encapsulated in the fatty emulsion droplet afforded and elution.The method of the present invention solves the problems, such as that lipid emulsion droplet present in prior art and free drug separating degree are poor, measurement result is bigger than normal.This method degree of accuracy is high, reproducible, available for (the i.e. COO containing anion in the structures such as Alprostadil) medicine fat emulsion formulation formulation and technology research and quality control.

Description

A kind of method and its application for determining fat emulsion formulation entrapment efficiency
Technical field
The invention belongs to Pharmaceutical Analysis technical field, is used to determine fat emulsion formulation entrapment efficiency more particularly to one kind Method and this method in the encapsulated Fat Emulsion medicine of separation and the application in not encapsulated Fat Emulsion medicine.
Background technology
The method of measure fat emulsion formulation envelop rate mainly has following several at present:
First method is the envelop rate using ultrafiltration centrifugal determination fat emulsion formulation, and emulsion droplet is retained using milipore filter, So as to be centrifuged out aqueous phase.Attempted during experiment using the super filter tube (3K, 5K, 10K) of Sai Duolisi and bohr measure Alprostadil liposome The envelop rate of fat emulsion injection (its chemical constitution is as follows).But find in practice, different filter membranes is equal to Alprostadil There is different degrees of suction-operated, that is to say, that the envelop rate of prostadil fatty emulsion injection is determined using this method to lead Cause measurement result bigger than normal.
The chemical structural formula of Alprostadil is as follows:
Second method is the envelop rate using dialysis measure fat emulsion formulation.This method can handle larger amount of sample Product, but larger amount of dialyzate and longer time are needed, and need constantly to change dialyzate.In addition, this method is uncomfortable For being insoluble in the medicine of water.Inventor once using this method measure prostadil fatty emulsion injection envelop rate, but due to The medicine specification (5 μ g/ml) is smaller, and is slightly soluble in water, it is necessary to give by free drug using substantial amounts of water, determines again afterwards The concentration of free drug.Because the amount of dilution to free drug is very big, therefore using this round-about way measure envelop rate When in the presence of certain limitation, the concentration of the Alprostadil in its dialyzate does not reach the test limit of liquid phase measurement.
The third method is the envelop rate using dextran microgel column measure drug-loaded liposome.Gathered by first removing Portugal Water in sugared microgel column, then drug-loaded emulsion is loaded on dextran microgel column, centrifugation elution liposome;Then Containing for the medicine that the total content concentration of medicine and dextran microgel column are encapsulated after eluting in drug-loaded emulsion is determined respectively Concentration is measured, the total content concentration of medicine obtains in the content concn divided by Fat Emulsion of the medicine being encapsulated after glucan microtrabeculae is eluted To the envelop rate of drug-loaded liposome.Inventor also once attempted to determine the encapsulating of prostadil fatty emulsion injection in this way Rate, but when doing the Method validation of this method, find when using free Alprostadil loading, free Alprostadil It is eluted, that is to say, that lipid emulsion droplet and free drug separating degree are poor, so can cause the measurement result of envelop rate not Accurately.
The content of the invention
For problems of the prior art, the present invention provides a kind of side for determining fat emulsion formulation entrapment efficiency Method, this method comprise the following steps:
(1) weak-base anion-exchange resin is filled in column jecket, be dehydrated;
(2) fat emulsion formulation of anion-containing medicine is added in column jecket, then eluted;
(3) collect the fatty emulsion droplet that affords, according to the medicament contg being encapsulated in the fatty emulsion droplet afforded with And the drug dose of fat emulsion formulation calculates the entrapment efficiency in fat emulsion formulation before elution.
Calculation formula:
Preferably, in above-mentioned steps (1), the weak-base anion-exchange resin is DEAE Ago-Gels FF.
Preferably, in above-mentioned steps (1), the dehydration is centrifugal dehydration or vacuum suction dehydration.
Preferably, in above-mentioned steps (2), the anion-containing medicine is carboxylic medicine;It is it is highly preferred that described The fat emulsion formulation of anion-containing medicine is alprostadil injection.
Preferably, in above-mentioned steps (2), the volume of the fat emulsion formulation for the anion-containing medicine being loaded into column jecket For the 1%-100% of column volume, preferably 15%-25%.The fat emulsion formulation for the anion-containing medicine being loaded into column jecket Volume cross conference and cause weak-base anion-exchange resin to overload, not encapsulated medicine is also eluted, and influences to separate With measure effect.
Preferably, in above-mentioned steps (2), the elution is centrifugation elution or pressurization elution.It is highly preferred that the centrifugation The condition of elution is the first centrifugation 1-10 minutes with 500-3000rpm, then carries out secondary elution with water;More preferably, The condition of the centrifugation elution is the first centrifugation 2-8 minutes with 800-2000rpm, then carries out secondary elution with water;Enter Preferably, the secondary elution is centrifugation elution or pressurization elution to one step;Still further preferably, the secondary elution carries out 1- 20 times, each water consumption is the 1-200%, preferably 10-50% of column volume.The number of secondary elution should not be excessive, otherwise removes Cause beyond the Fat Emulsion for being encapsulated with medicine in column jecket is eluted, to also result in not encapsulated medicine and be also eluted down Come, influence the accuracy of entrapment efficiency determination.
The method of the present invention is using the entrapment efficiency of weak-base anion-exchange resin post measure fat emulsion formulation, the party Method contains anion (such as carboxy CO O suitable for chemical constitution-Deng) medicine, such as Alprostadil.Noted with Alprostadil Penetrate exemplified by liquid, DEAE (diethyllaminoethyl) weak-base anion-exchange resin that this method uses can adsorb Alprostadil completely The Alprostadil to dissociate in Fat Emulsion, and wrapped Alprostadil can quickly be eluted by water, with realizing free forefront You are kept completely separate with wrapping up the lipid emulsion droplet of Alprostadil, so as to carry out the Accurate Determining of entrapment efficiency.
The method of the present invention solves that lipid emulsion droplet present in prior art and free drug separating degree be poor, measurement result The problem of bigger than normal.This method degree of accuracy is high, reproducible, the fat available for the medicine containing anion in the structures such as Alprostadil The formulation and technology research and quality control of fat emulsion formulation.
The present invention also provide it is a kind of by the fat emulsion formulation of anion-containing medicine be encapsulated medicine with it is not encapsulated Medical separation method, this method comprises the following steps:
(a) weak-base anion-exchange resin is filled in column jecket, be dehydrated;
(b) fat emulsion formulation of anion-containing medicine is added in column jecket, then eluted, collect what is afforded Fatty emulsion droplet.
Preferably, in above-mentioned steps (a), the weak-base anion-exchange resin exchanges for DEAE weakly-basic anions Resin;It is highly preferred that the weak-base anion-exchange resin is DEAE Ago-Gels FF.
Preferably, in above-mentioned steps (a), the dehydration is centrifugal dehydration or vacuum suction dehydration.
Preferably, in above-mentioned steps (b), the anion-containing medicine is carboxylic medicine;It is it is highly preferred that described The fat emulsion formulation of anion-containing medicine is alprostadil injection.
Preferably, in above-mentioned steps (b), the volume of the fat emulsion formulation for the anion-containing medicine being loaded into column jecket For the 1%-100% of column volume, preferably 15%-25%.
Preferably, in above-mentioned steps (b), the elution is centrifugation elution or pressurization elution.It is highly preferred that the centrifugation The condition of elution is the first centrifugation 1-10 minutes with 500-3000rpm, then carries out secondary elution with water;More preferably, The condition of the centrifugation elution is the first centrifugation 2-8 minutes with 800-2000rpm, then carries out secondary elution with water;Enter Preferably, the secondary elution is centrifugation elution or pressurization elution to one step;Still further preferably, the secondary elution carries out 1- 20 times, each water consumption is the 1-200%, preferably 10-50% of column volume.The number of secondary elution should not be excessive, otherwise removes Cause beyond the Fat Emulsion for being encapsulated with medicine in column jecket is eluted, to also result in not encapsulated medicine and be also eluted down Come, so as to influence the effect of separation.
Preferably, it is of the invention by the medicine being encapsulated in the fat emulsion formulation of anion-containing medicine and not encapsulated medicine The method of thing separation is additionally included in after step (b), by medicament elution not encapsulated in column jecket.
The present invention also provides application of the weak-base anion-exchange resin in Fat Emulsion pharmaceutical preparation envelop rate is determined.It is excellent Selection of land, the weak-base anion-exchange resin are DEAE weak-base anion-exchange resins;It is highly preferred that the alkalescent is cloudy Ion exchange resin is DEAE Ago-Gels FF.
The present invention also provides weak-base anion-exchange resin quilt in the fat emulsion formulation for separating anion-containing medicine The medicine of encapsulating and the application in not encapsulated medicine.Preferably, the weak-base anion-exchange resin is DEAE weak base Property anion exchange resin;It is highly preferred that the weak-base anion-exchange resin is DEAE Ago-Gels FF.
Embodiment
Below by specific embodiment, the present invention will be described in more detail.Although it is directed to it should be appreciated that only listing The embodiment of alprostadil injection, but in view of the property of weak-base anion-exchange resin in itself, method of the invention Suitable for the fat emulsion formulation of other anion-containing medicines.
Embodiment 1
(1) DEAE weak-base anion-exchange resins are filled in 5ml syringe sleeves, centrifugal dehydration, form 5ml's Dry post;
(2) alprostadil injection 1ml is loaded into syringe sleeve, 3 points is centrifuged with 1200rpm centrifugal speed Clock;
(3) every time with 1ml water centrifugation elution, co-elute 7 times;The emulsion droplet eluted is collected into 10ml measuring bottles simultaneously Constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.Parallel test is three times, as a result as follows:
Embodiment 2
(1) DEAE weak-base anion-exchange resins are filled in 10ml syringe sleeves, centrifugal dehydration, form 10ml Dry post;
(2) alprostadil injection 5ml is added in syringe sleeve, centrifuged 8 minutes with 2000rpm centrifugal speed;
(3) every time with 2ml water centrifugation elution, co-elute 5 times;The emulsion droplet eluted is collected into 20ml measuring bottles simultaneously Constant volume, measure obtain being encapsulated the content of medicine, theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 3
(1) DEAE weak-base anion-exchange resins are filled in 50ml column jeckets, centrifugal dehydration, form the dry of 50ml Post;
(2) alprostadil injection 1ml is added in column jecket, centrifuged 2 minutes with 3000rpm centrifugal speed;
(3) every time with 1ml water centrifugation elution, co-elute 20 times;The emulsion droplet eluted is collected into 25ml measuring bottles And constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 4
(1) DEAE weak-base anion-exchange resins are filled in 100ml column jeckets, centrifugal dehydration, form the dry of 100ml Post;
(2) alprostadil injection 1ml is added in column jecket, centrifuged 2 minutes with 500rpm centrifugal speed;
(3) every time with 1ml water centrifugation elution, co-elute 7 times;The emulsion droplet eluted is collected into 10ml measuring bottles simultaneously Constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 5
(1) DEAE weak-base anion-exchange resins are filled in 5ml column jeckets, centrifugal dehydration, form 5ml dry post;
(2) by alprostadil injection 0.5ml loadings, centrifuged 1 minute with 1500rpm centrifugal speed;
(3) every time with 4ml water centrifugation elution, co-elute 2 times;The emulsion droplet that collection elutes is transferred to 10ml measuring bottles In and constant volume, measure obtain be encapsulated medicine content.Theoretical concentration alprostadil injection being diluted to after post, same to method Measure, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 6
(1) DEAE weak-base anion-exchange resins are filled in 10ml column jeckets, centrifugal dehydration, form the dry of 10ml Post;
(2) alprostadil injection 0.5ml is added in column jecket, centrifuged 5 minutes with 1000rpm centrifugal speed;
(3) every time with 0.5ml water centrifugation elution, co-elute 6 times;The emulsion droplet that collection elutes is transferred to 5ml amounts In bottle and constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, together Method determines, and then calculates the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 7
(1) DEAE weak-base anion-exchange resins are filled in 10ml column jeckets, centrifugal dehydration, form the dry of 10ml Post;
(2) alprostadil injection 0.2ml is added in column jecket, with 2000rpm, centrifugal speed centrifuges 1 minute;
(3) every time with 0.2ml water centrifugation elution, co-elute 20 times;The emulsion droplet eluted is collected into 5ml measuring bottles And constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 8
(1) DEAE weak-base anion-exchange resins are filled in 3ml column jeckets, centrifugal dehydration, form 3ml dry post;
(2) alprostadil injection 1ml is added in column jecket, centrifuged 2 minutes with 800rpm centrifugal speed;
(3) every time with 1ml water centrifugation elution, co-elute 8 times;The emulsion droplet eluted is collected into 10ml measuring bottles simultaneously Constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 9
(1) DEAE weak-base anion-exchange resins are filled in 5ml column jeckets, centrifugal dehydration, form 5ml dry post;
(2) alprostadil injection 2.5ml is added in column jecket, centrifuged 3 minutes with 1000rpm centrifugal speed;
(3) every time with 1ml water centrifugation elution, co-elute 7 times;The fatty emulsion droplet eluted is collected into 10ml measuring bottles In and constant volume, measure obtain be encapsulated medicine content.Theoretical concentration alprostadil injection being diluted to after post, same to method Measure, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Embodiment 10
(1) DEAE weak-base anion-exchange resins are filled in 4ml column jeckets, centrifugal dehydration, form 4ml dry post;
(2) alprostadil injection 1ml is added in column jecket, centrifuged 10 minutes with 500rpm centrifugal speed;
(3) every time with 8ml water centrifugation elution, co-elute 1 time;The emulsion droplet eluted is collected into 25ml measuring bottles simultaneously Constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.
Parallel test is three times, as a result as follows:
Comparative example 1 (dextran microgel column method)
(1) G50 sephadexes are filled in 5ml syringe sleeves, centrifugal dehydration, form 5.5ml dry post;
(2) alprostadil injection 0.5ml is loaded into syringe sleeve, 2 points is centrifuged with 1200rpm centrifugal speed Clock;
(3) every time with 1ml water centrifugation elution, co-elute 2 times;The emulsion droplet eluted is collected into 5ml measuring bottles simultaneously Constant volume, measure obtain being encapsulated the content of medicine.Theoretical concentration alprostadil injection being diluted to after post, surveyed with method It is fixed, then calculate the envelop rate of alprostadil injection.Parallel test is three times, as a result as follows:
It can be seen that the envelop rate for filling to obtain with G50 sephadexes is lower.Method has been carried out with this G50 sephadex Learn and investigate.Conclusion is:The independent loading of free drug, washing steps are slightly more, and free drug can be eluted, and as a result can cause to wrap Envelope rate measurement result is higher.Thus, in order to control effective combination of free drug and pillar, reduce water washing time, but lead The emulsion droplet rate of recovery is caused to decline, thus the measurement result of envelop rate is relatively low.Therefore compared with G50 sephadexes, DEAE anion Exchanger resin has more preferable.
Comparative example 2 (ultrafiltration centrifugal process)
(1) alprostadil injection 0.5ml is added in 100k ultra-filtration centrifuge tubes, after trim rotor, 18000G centrifugations 20 Minute;
(2) aqueous solution for taking ultra-filtration centrifuge tube lower floor to filter directly determines.
Experiment is three times, as a result as follows:
It can be seen that the envelop rate obtained with ultrafiltration centrifugal process is very high.Methodological study, conclusion have been carried out to ultrafiltration centrifugal process For:The free drug aqueous solution (micro ethanol hydrotropy) is centrifuged with different pore size material super filter tube, and free drug has absorption and made With adsorption rate minimum 40% or so.Part free drug will not be eluted, and as a result cause entrapment efficiency determination result inclined Height, influence the accuracy of result.Therefore compared with ultrafiltration centrifugal process, DEAE anion exchange resin has more preferable.

Claims (10)

1. a kind of method for determining fat emulsion formulation entrapment efficiency, the described method comprises the following steps:
(1) weak-base anion-exchange resin is filled in column jecket, be dehydrated;
(2) fat emulsion formulation of anion-containing medicine is added in column jecket, then eluted;
(3) Fat Emulsion afforded is collected, according to the content for the medicine being encapsulated in the fatty emulsion droplet afforded and is washed The dosage of the medicine of fat emulsion formulation calculates the entrapment efficiency of fat emulsion formulation before de-;
Preferably, the weak-base anion-exchange resin is DEAE weak-base anion-exchange resins, more preferably DEAE fine jades Sepharose FF;
Preferably, in step (1), the dehydration is centrifugal dehydration or vacuum suction dehydration;
Preferably, in step (2), the fat emulsion formulation of the anion-containing medicine is alprostadil injection;
Preferably, in step (2), the volume of the fat emulsion formulation for the anion-containing medicine being loaded into column jecket is column volume 1%-100%, preferably 15%-25%.
2. according to the method for claim 1, it is characterised in that in step (2), the elution is centrifugation elution or pressurization Elution.
3. according to the method for claim 2, it is characterised in that the condition of the centrifugation elution is first with 500-3000rpm Centrifugation 1-10 minutes, then carry out secondary elution with water;It is highly preferred that the condition of the centrifugation elution is first with 800- 2000rpm centrifugation 2-8 minutes, then carry out secondary elution with water.
4. according to the method for claim 3, it is characterised in that the secondary elution is centrifugation elution or pressurization elution;It is excellent Selection of land, the secondary elution are carried out 1-20 times, and each water consumption is the 1-200%, more preferably 10-50% of column volume.
It is 5. a kind of by the medicine being encapsulated in the fat emulsion formulation of anion-containing medicine and not encapsulated medical separation Method, this method comprise the following steps:
(a) weak-base anion-exchange resin is filled in column jecket, be dehydrated;
(b) fat emulsion formulation of anion-containing medicine is added in column jecket, then eluted, collect the fat afforded Emulsion droplet;
Preferably, in step (a), the weak-base anion-exchange resin is DEAE weak-base anion-exchange resins;More Preferably, the weak-base anion-exchange resin is DEAE Ago-Gels FF.
Preferably, in step (a), the dehydration is centrifugal dehydration or vacuum suction dehydration;
Preferably, in step (b), the fat emulsion formulation of the anion-containing medicine is alprostadil injection;
Preferably, in step (b), the volume of the fat emulsion formulation for the anion-containing medicine being loaded into column jecket is column volume 1%-100%;Preferably 15%-25%.
6. according to the method for claim 5, it is characterised in that in above-mentioned steps (b), it is described elution for centrifugation elution or Pressurization elution.
7. according to the method for claim 5, it is characterised in that the condition of the centrifugation elution is first with 500-3000rpm Centrifugation 1-10 minutes, then carry out secondary elution with water;Preferably, the condition of the centrifugation elution is first with 800- 2000rpm centrifugation 2-8 minutes, then carry out secondary elution with water;It is highly preferred that the secondary elution is centrifugation elution Or pressurization elution;More preferably, the secondary elution is carried out 1-20 times, and each water consumption is the 1-200% of column volume, is preferably 10-50%.
8. according to the method for claim 5, it is characterised in that methods described is additionally included in after step (b), by column jecket Not encapsulated medicament elution.
9. weak-base anion-exchange resin answering in the entrapment efficiency of fat emulsion formulation of anion-containing medicine is determined With;Preferably, the weak-base anion-exchange resin is DEAE weak-base anion-exchange resins;It is it is highly preferred that described weak Alkalescence anion-exchange resin is DEAE Ago-Gels FF.
10. the medicine that weak-base anion-exchange resin is encapsulated in the fat emulsion formulation for separating anion-containing medicine with not Application in encapsulated medicine;Preferably, the weak-base anion-exchange resin is that DEAE weakly-basic anions exchange tree Fat;It is highly preferred that the weak-base anion-exchange resin is DEAE Ago-Gels FF.
CN201610861952.1A 2016-09-29 2016-09-29 Method for measuring drug encapsulation efficiency of fat emulsion preparation and application thereof Active CN107884529B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610861952.1A CN107884529B (en) 2016-09-29 2016-09-29 Method for measuring drug encapsulation efficiency of fat emulsion preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610861952.1A CN107884529B (en) 2016-09-29 2016-09-29 Method for measuring drug encapsulation efficiency of fat emulsion preparation and application thereof

Publications (2)

Publication Number Publication Date
CN107884529A true CN107884529A (en) 2018-04-06
CN107884529B CN107884529B (en) 2020-12-08

Family

ID=61769876

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610861952.1A Active CN107884529B (en) 2016-09-29 2016-09-29 Method for measuring drug encapsulation efficiency of fat emulsion preparation and application thereof

Country Status (1)

Country Link
CN (1) CN107884529B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109541158A (en) * 2018-12-12 2019-03-29 上海景峰制药有限公司 A kind of measuring method of the encapsulation rate of liposome medicament
CN110824122A (en) * 2019-10-29 2020-02-21 江苏盈科生物制药有限公司 In-vitro release model and in-vitro release method of propofol fat emulsion injection

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1621092A (en) * 2003-11-25 2005-06-01 杨正茂 Folic acid receptor targeted liposome medicine carrier, its preparation and application
CN1828292A (en) * 2005-03-02 2006-09-06 广东药学院 Method for determining capsaicin flexible liposome encapsulation rate using dextran microgel column
CN101017164B (en) * 2006-07-21 2011-08-31 上海中医药大学 Determination method for entrapment efficiency of liposome
CN103185761A (en) * 2011-12-27 2013-07-03 天津药物研究院 Method for measuring entrapment efficiency of vincristine sulfate lipidosome by glucan gel chromatography
CN103536532A (en) * 2013-10-25 2014-01-29 北京蓝丹医药科技有限公司 Alprostadil composition as well as preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1621092A (en) * 2003-11-25 2005-06-01 杨正茂 Folic acid receptor targeted liposome medicine carrier, its preparation and application
CN1828292A (en) * 2005-03-02 2006-09-06 广东药学院 Method for determining capsaicin flexible liposome encapsulation rate using dextran microgel column
CN101017164B (en) * 2006-07-21 2011-08-31 上海中医药大学 Determination method for entrapment efficiency of liposome
CN103185761A (en) * 2011-12-27 2013-07-03 天津药物研究院 Method for measuring entrapment efficiency of vincristine sulfate lipidosome by glucan gel chromatography
CN103536532A (en) * 2013-10-25 2014-01-29 北京蓝丹医药科技有限公司 Alprostadil composition as well as preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
吴瑾瑾 等: "猕猴桃根多糖脂质体包封率测定方法研究", 《中国实验方剂学杂志》 *
尹鸿萍等: "螺旋藻多糖脂质体包封率的测定 ", 《中国生化药物杂志》 *
徐缓等: "阴离子交换树脂-微柱离心法测定钙黄绿素脂质体包封率", 《药物分析杂志》 *
肖明辉等: "前列地尔的剂型及研究进展 ", 《中国药房》 *
赵明明等: "载药脂肪乳注射液的研究进展 ", 《沈阳药科大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109541158A (en) * 2018-12-12 2019-03-29 上海景峰制药有限公司 A kind of measuring method of the encapsulation rate of liposome medicament
CN110824122A (en) * 2019-10-29 2020-02-21 江苏盈科生物制药有限公司 In-vitro release model and in-vitro release method of propofol fat emulsion injection

Also Published As

Publication number Publication date
CN107884529B (en) 2020-12-08

Similar Documents

Publication Publication Date Title
CN104777249B (en) The method measuring effective ingredient amygdaloside content in cough syrup of loquat leaf
CN107884529A (en) A kind of method and its application for determining fat emulsion formulation entrapment efficiency
CN103604879B (en) Detection method of polystictus versicolor and preparation containing polystictus versicolor
CN102955008B (en) Method for detecting sulfonamide residue in eel by pressurized capillary electrochromatography
CN103822975B (en) A kind of detection method of formulation of ' Sheng Mai ' of Radix Codonopsis side
CN102670951B (en) The content assaying method of Hesperidin in a kind of Chinese medicine composition
CN106770849A (en) A kind of detection method for determining doxercalciferol and its impurities
CN109633003A (en) Radix Polygalae mouth mountain ketone III and 3,6 in a kind of measurement Radix Polygalae, the method for-two mustard acyl cane sugar contents
CN107831231A (en) A kind of method for detecting vitamin A impurity in multivitamin preparation
CN102539575A (en) Method for detecting content of beta-lactoglobulin in dairy product
CN102980963A (en) Method for determining drug encapsulation efficiency in liposomes
CN106546684B (en) A kind of detection method of Alprostadil freeze-dried liplid emulsions
CN104277086A (en) Extraction method of scutellarin in scutellariae barbatae
CN103764158A (en) Anti-tachyarrhythmia formulation and preparation method thereof
CN107300599A (en) A kind of method of acidic drug in SPE liquid chromatogram combination examination liquid medicine
CN107389827A (en) The assay method of stachydrine hydrochloride content in motherwort or its compound preparation
CN107441047A (en) A kind of preparation method of the dendrobine liposome based on Active loading mode
CN102706994B (en) Qualitative and quantitative detection method for tartronic acid in cucumbers
CN104215703B (en) The detection method of glycoside macromolecular substances in a kind of injection Yiqi and vein recovery
CN103145528A (en) Method of preparing high-purity polyprenol lipid by means of both high-speed countercurrent chromatography and high performance liquid chromatography
CN103185761A (en) Method for measuring entrapment efficiency of vincristine sulfate lipidosome by glucan gel chromatography
CN100434135C (en) Method for separating and purifying natural product using three-phase counter current chromatograph
CN116818935B (en) Method for detecting encapsulation rate of alprostadil injection
CN103630508B (en) Method for measuring encapsulation efficiency of doxorubicin hydrochloride liposomal
CN106706825B (en) Method for determining content of tetrahydropalmatine in bergamot Rupining

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: No.18-1, Nanping East Road, Hunnan New District, Shenyang City, Liaoning Province

Patentee after: Yuanda Life Science (Liaoning) Co.,Ltd.

Address before: No.18-1, Nanping East Road, Hunnan New District, Shenyang City, Liaoning Province

Patentee before: LIAONING GRAND NUOKANG BIOPHARMACEUTICAL Co.,Ltd.

PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A method for determining drug entrapment efficiency of fat emulsion preparation and its application

Effective date of registration: 20220517

Granted publication date: 20201208

Pledgee: Bank of China Limited Shenyang Tiexi sub branch

Pledgor: Yuanda Life Science (Liaoning) Co.,Ltd.

Registration number: Y2022210000044

PC01 Cancellation of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20230815

Granted publication date: 20201208

Pledgee: Bank of China Limited Shenyang Tiexi sub branch

Pledgor: Yuanda Life Science (Liaoning) Co.,Ltd.

Registration number: Y2022210000044